Bi-specific T cell engagers (BiTEs) are genetically engineered recombinant proteins that have been shown to activate cytotoxic T cells through the CD3 complex, while also targeting activated T cells to tumor cells via a tumor-specific domain. The gene discussed is CACNA1A; the disease is neoplasm.